Skip to content

UNCY - Unicycive Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchU

Unicycive Therapeutics Inc

UNCY · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

U

UNCYUnicycive Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $8.74
52-wk low: $3.71
Prev close: $7.21
Mkt cap: $152.9M
Fwd P/E: 3.4x
Beta: 1.78

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$13.5M

MW
Marshall Wace
Q2 2026 13F
$2.6M
position
MI
Millennium
Israel Englander · Q2 2026 13F

Earnings

Reported May 12, 2026

Earnings came in 13.6% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Forward P/E: 3.44
Market cap: $153M

Valuation

P/S23.75
P/B2.94

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: UNCY
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $152.85M
Beta: 1.78

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

23.8x

P/B

2.9x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-101.1%

$1.3M

position

SQ

Squarepoint

Q4 2025 13F

$319K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for UNCY

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.54-13.6%

-$0.47 expected

Next report

What the street expects next

EPS expected

-$0.32

-$0.40 to -$0.23

Revenue expected

$0.00

8 analysts

Last 30 days

2up1down

Analysts raising estimates

Estimate drift

+0.02

Change in 30 days

-101.1%

ROA-40.6%

Growth

Beta1.78